150 related articles for article (PubMed ID: 12053422)
21. Collaboration in health technology assessment (EUnetHTA joint action, 2010-2012): four case studies.
Huić M; Nachtnebel A; Zechmeister I; Pasternak I; Wild C
Int J Technol Assess Health Care; 2013 Jul; 29(3):323-30. PubMed ID: 23759333
[TBL] [Abstract][Full Text] [Related]
22. European Collaboration in Health Technology Assessment (HTA): goals, methods and outcomes with specific focus on medical devices.
Erdös J; Ettinger S; Mayer-Ferbas J; de Villiers C; Wild C
Wien Med Wochenschr; 2019 Sep; 169(11-12):284-292. PubMed ID: 30725440
[TBL] [Abstract][Full Text] [Related]
23. Health promotion and disease prevention as a complement to community health indicators. Working group 1.
Dauben HP; Førde OH; Loud ML; Isacsson SO; Paccaud F; Sanchez E; Steiger TS
Int J Technol Assess Health Care; 2002; 18(2):238-72. PubMed ID: 12053424
[No Abstract] [Full Text] [Related]
24. [HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality].
Nachtnebel A; Mayer J; Erdös J; Lampe K; Kleijnen S; Schnell-Inderst P; Wild C
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):291-9. PubMed ID: 26354129
[TBL] [Abstract][Full Text] [Related]
25. Development of health technology assessment in Europe. A personal perspective.
Jonsson E
Int J Technol Assess Health Care; 2002; 18(2):171-83. PubMed ID: 12053417
[No Abstract] [Full Text] [Related]
26. EUR-ASSESS Project Subgroup report on Methodology. Methodological guidance for the conduct of health technology assessment.
Liberati A; Sheldon TA; Banta HD
Int J Technol Assess Health Care; 1997; 13(2):186-219. PubMed ID: 9194352
[No Abstract] [Full Text] [Related]
27. Health technology assessment and health care in the European Union.
Banta D; Oortwijn W
Int J Technol Assess Health Care; 2000; 16(2):626-35. PubMed ID: 10932427
[TBL] [Abstract][Full Text] [Related]
28. Navigating joint HTA, procurement, and fair pricing: evidence-based insights and practical recommendations - A meeting report from ISPOR regional conference in Warsaw, 2019.
Inotai A; Németh B
Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):379-381. PubMed ID: 31159614
[No Abstract] [Full Text] [Related]
29. INTEGRATE-HTA: THE PERSPECTIVE OF EUnetHTA.
Lampe K; Schnell-Inderst P
Int J Technol Assess Health Care; 2017 Jan; 33(5):605-608. PubMed ID: 28874222
[TBL] [Abstract][Full Text] [Related]
30. Strengthening Europe's epidemic intelligence capacity: the first collaboration between a European Union Member State and the European Centre for Disease Prevention and Control.
Coulombier D; Ciotti M; Freitas G; Frota A; Varela C; Vasconcelos P; Fernandes T
Euro Surveill; 2008 Feb; 13(6):. PubMed ID: 18445423
[No Abstract] [Full Text] [Related]
31. International comparison and review of a health technology assessment skills program.
Wanke MI; Juzwishin D
Int J Technol Assess Health Care; 2005; 21(2):253-62. PubMed ID: 15921067
[TBL] [Abstract][Full Text] [Related]
32. [France in the European and International research landscape].
Julkowska D
Med Sci (Paris); 2018 May; 34 Hors série n°1():55-57. PubMed ID: 29911567
[No Abstract] [Full Text] [Related]
33. Health Technology Assessment as a Priority-Setting Tool for Universal Health Coverage: The Call for Global Action at the Prince Mahidol Award Conference 2016.
Teerawattananon Y; Luz A
Pharmacoeconomics; 2016 Jan; 34(1):1-3. PubMed ID: 26660528
[No Abstract] [Full Text] [Related]
34. Managing Legionnaires' disease in Europe: the need for international collaboration.
Joseph C
Euro Surveill; 2007 Nov; 12(11):E1-2. PubMed ID: 18005651
[No Abstract] [Full Text] [Related]
35. Agreements and practical experience of trauma care cooperation in Central Europe: the "Boundless Trauma Care Central Europe" (BTCCE) project.
Jabakhanji SB; Meier TM; Ramakers-van Kuijk MA; Brink PR; Andruszkow H; Krafft T; Pape HC
Injury; 2015 Apr; 46(4):519-24. PubMed ID: 25795394
[No Abstract] [Full Text] [Related]
36. Health technology assessment of medical devices: What is different? An overview of three European projects.
Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
[TBL] [Abstract][Full Text] [Related]
37. Relative effectiveness and the European pharmaceutical market.
Jönsson B
Eur J Health Econ; 2011 Apr; 12(2):97-102. PubMed ID: 21267624
[No Abstract] [Full Text] [Related]
38. European Union: Royal Society helps guide Brexit science.
Maxton J
Nature; 2016 Aug; 536(7616):274. PubMed ID: 27535524
[No Abstract] [Full Text] [Related]
39. INTRODUCTION OF HEALTH TECHNOLOGY ASSESSMENT FOR MEDICINES IN SLOVAKIA.
Tesar T; Hloska A; Wawruch M; Lehocka L; Snopkova M; Masarykova L
Int J Technol Assess Health Care; 2017 Jan; 33(3):345-349. PubMed ID: 28434416
[TBL] [Abstract][Full Text] [Related]
40. Moving the boundaries of international collaboration on clinical trials and QoL: experiences in oncology and legislation within the European Parliament.
Bottomley A; Kirby T; Bean J; Walker J
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):43-5. PubMed ID: 23402444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
